A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification
Sepsis is a potentially life–threatening complication of infection and diagnosis depends on rapid assessment of leukocyte count and CD64 expression. Here the authors present a microfluidic chip that can quantify these parameters from minimal amounts of whole blood with no manual processing.
Main Authors: | U. Hassan, T. Ghonge, B. Reddy Jr., M. Patel, M. Rappleye, I. Taneja, A. Tanna, R. Healey, N. Manusry, Z. Price, T. Jensen, J. Berger, A. Hasnain, E. Flaugher, S. Liu, B. Davis, J. Kumar, K. White, R. Bashir |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms15949 |
Similar Items
-
Sample Preparation on Microfluidic Biochips
by: Liu, Chia-Hung, et al.
Published: (2015) -
Magnetic nanochain integrated microfluidic biochips
by: Qirong Xiong, et al.
Published: (2018-05-01) -
Development of automated microfluidic biochip platforms
by: Hsiao, Yi-Hsing, et al.
Published: (2017) -
Piracy Prevention of Digital Microfluidic Biochips
by: Hsieh, Ching-Wei, et al.
Published: (2017) -
The Business Competitive Advantage and Strategy of Biochip Industry-Taking Microfluidic Biochip as an Example
by: Jian-zhong Wang, et al.